Omaha, NE – Streck’s A1c-Cellular® is now assayed for the Beckman Coulter® AU Series.
A1c-Cellular is the first and only HbA1c control with intact red blood cells. It tests the entire HbA1c procedure, including the lysing of the red blood cell – a step omitted with other controls.
A1c-Cellular is a ready-to-use liquid control. No need for reconstitution reduces the potential for human error. A1c-Cellular is available in two clinically significant levels and is appropriate for immunoassay and ionic exchange HPLC methodologies and assayed for popular chemistry instruments.
A1c-Cellular is available in 2.0 mL plastic cap-pierceable vials which allow for autosampling by an analyzer. Product stability is 180 days closed-vial and 30 days open-vial.
Streck’s interlaboratory quality control program, STATS®, provides customers with evaluation of their instrument’s performance against a peer group comprised of other labs using the same instrument, method and product lot. The online report program, STATS-Link®, now includes real-time reporting. Customers may enter data online and access real-time reports immediately, compare control results to other laboratories any time, utilize rapid turnaround times and recognize trends or shifts sooner and increase confidence in instrument performance. The program is open to all customers at no charge.
About Streck, Inc.
Established in 1971, Streck develops and manufactures products for clinical and research laboratories. Streck’s passion for innovation, quality and service has allowed the organization to become a world leader in the development of quality control and diagnostic products that help laboratories ensure accurate and timely results for patients. Streck offers the industry’s leading automated erythrocyte sedimentation rate instrument and is a worldwide supplier of blood collection tubes that standardize methods for sample collection, stabilization and transportation. Expanding product lines include flow cytometry, body fluids and urinalysis with emerging products being developed for the burgeoning field of molecular diagnostics. For more information, visit www.streck.com.